Trial · NCT01705236
Adverse events35
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 35
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Fingolimod - Longitudinal Assessment | 9 | 87 | |
| other | DIARRHOEA | Gastrointestinal disorders | Fingolimod - Longitudinal Assessment | 6 | 87 | |
| other | BRONCHITIS | Infections and infestations | Fingolimod - Longitudinal Assessment | 6 | 87 | |
| other | CONJUNCTIVITIS | Infections and infestations | Fingolimod - Longitudinal Assessment | 5 | 87 | |
| other | NASOPHARYNGITIS | Infections and infestations | Fingolimod - Longitudinal Assessment | 41 | 87 | |
| other | SINUSITIS | Infections and infestations | Fingolimod - Longitudinal Assessment | 6 | 87 | |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | Fingolimod - Longitudinal Assessment | 7 | 87 | |
| other | URINARY TRACT INFECTION | Infections and infestations | Fingolimod - Longitudinal Assessment | 7 | 87 | |
| other | VITAMIN D DEFICIENCY | Metabolism and nutrition disorders | Fingolimod - Longitudinal Assessment | 8 | 87 | |
| other | ARTHRALGIA | Musculoskeletal and connective tissue disorders | Fingolimod - Longitudinal Assessment | 5 | 87 | |
| other | BACK PAIN | Musculoskeletal and connective tissue disorders | Fingolimod - Longitudinal Assessment | 7 | 87 | |
| other | DIZZINESS | Nervous system disorders | Fingolimod - Longitudinal Assessment | 5 | 87 | |
| other | HEADACHE | Nervous system disorders | Fingolimod - Longitudinal Assessment | 10 | 87 | |
| other | MULTIPLE SCLEROSIS RELAPSE | Nervous system disorders | Fingolimod - Longitudinal Assessment | 21 | 87 | |
| other | PARAESTHESIA | Nervous system disorders | Fingolimod - Longitudinal Assessment | 5 | 87 | |
| other | DEPRESSION | Psychiatric disorders | Fingolimod - Longitudinal Assessment | 5 | 87 | |
| other | COUGH | Respiratory, thoracic and mediastinal disorders | Fingolimod - Longitudinal Assessment | 6 | 87 | |
| other | ALOPECIA | Skin and subcutaneous tissue disorders | Fingolimod - Longitudinal Assessment | 5 | 87 | |
| other | HYPERTENSION | Vascular disorders | Fingolimod - Longitudinal Assessment | 12 | 87 | |
| serious | AORTIC VALVE INCOMPETENCE | Cardiac disorders | Fingolimod - Longitudinal Assessment | 1 | 87 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01705236/events